JP2021136883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021136883A5 JP2021136883A5 JP2020035297A JP2020035297A JP2021136883A5 JP 2021136883 A5 JP2021136883 A5 JP 2021136883A5 JP 2020035297 A JP2020035297 A JP 2020035297A JP 2020035297 A JP2020035297 A JP 2020035297A JP 2021136883 A5 JP2021136883 A5 JP 2021136883A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- liquid
- cryopreservation
- suspending
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000822 natural killer cell Anatomy 0.000 claims 12
- 239000007788 liquid Substances 0.000 claims 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 238000005138 cryopreservation Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims 2
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 claims 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 2
- 239000003613 bile acid Substances 0.000 claims 2
- 239000006143 cell culture medium Substances 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000001103 potassium chloride Substances 0.000 claims 2
- 235000011164 potassium chloride Nutrition 0.000 claims 2
- 239000001632 sodium acetate Substances 0.000 claims 2
- 235000017281 sodium acetate Nutrition 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000000176 sodium gluconate Substances 0.000 claims 2
- 235000012207 sodium gluconate Nutrition 0.000 claims 2
- 229940005574 sodium gluconate Drugs 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 238000010257 thawing Methods 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020035297A JP2021136883A (ja) | 2020-03-02 | 2020-03-02 | 高活性ｎｋ細胞の処理方法 |
| EP21765044.9A EP4151717A4 (en) | 2020-03-02 | 2021-03-02 | Method for treating highly active nk cells |
| PCT/JP2021/007863 WO2021177279A1 (ja) | 2020-03-02 | 2021-03-02 | 高活性ｎｋ細胞の処理方法 |
| KR1020227033295A KR20220148233A (ko) | 2020-03-02 | 2021-03-02 | 고활성 nk 세포의 처리 방법 |
| CN202180018428.7A CN115279887A (zh) | 2020-03-02 | 2021-03-02 | 高活性nk细胞的处理方法 |
| AU2021230860A AU2021230860A1 (en) | 2020-03-02 | 2021-03-02 | Method for treating highly active NK cells |
| US17/908,472 US20230109717A1 (en) | 2020-03-02 | 2021-03-02 | Method for treating highly active nk cells |
| TW110107331A TW202140770A (zh) | 2020-03-02 | 2021-03-02 | 高活性nk細胞之處理方法 |
| JP2023120214A JP2023126695A (ja) | 2020-03-02 | 2023-07-24 | 高活性ｎｋ細胞の処理方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020035297A JP2021136883A (ja) | 2020-03-02 | 2020-03-02 | 高活性ｎｋ細胞の処理方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023120214A Division JP2023126695A (ja) | 2020-03-02 | 2023-07-24 | 高活性ｎｋ細胞の処理方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021136883A JP2021136883A (ja) | 2021-09-16 |
| JP2021136883A5 true JP2021136883A5 (cg-RX-API-DMAC7.html) | 2022-08-29 |
Family
ID=77614337
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020035297A Pending JP2021136883A (ja) | 2020-03-02 | 2020-03-02 | 高活性ｎｋ細胞の処理方法 |
| JP2023120214A Pending JP2023126695A (ja) | 2020-03-02 | 2023-07-24 | 高活性ｎｋ細胞の処理方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023120214A Pending JP2023126695A (ja) | 2020-03-02 | 2023-07-24 | 高活性ｎｋ細胞の処理方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230109717A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4151717A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021136883A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220148233A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115279887A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021230860A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202140770A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021177279A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022342919A1 (en) * | 2021-09-08 | 2024-03-14 | Gaia Biomedicine Inc. | Method for treating cells |
| KR20250054056A (ko) | 2022-08-30 | 2025-04-22 | 가부시키가이샤 가이아바이오메디신 | 모노바디 및 nk 세포 |
| KR20250161543A (ko) * | 2023-03-15 | 2025-11-17 | 가부시키가이샤 가이아바이오메디신 | 세포를 현탁하기 위한 액 및 그 이용 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4385158B2 (ja) * | 2000-12-04 | 2009-12-16 | 株式会社リンフォテック | 細胞の保存液および該保存液を用いた細胞の保存方法 |
| JP4947948B2 (ja) | 2004-10-12 | 2012-06-06 | ニプロ株式会社 | 細胞保存液 |
| JPWO2011021618A1 (ja) | 2009-08-19 | 2013-01-24 | タカラバイオ株式会社 | 細胞の保存方法 |
| JP5996533B2 (ja) * | 2010-07-13 | 2016-09-21 | アントフロゲネシス コーポレーション | ナチュラルキラー細胞を生成させる方法 |
| US10202579B2 (en) * | 2012-11-29 | 2019-02-12 | Takara Bio Europe Ab | Methods for producing mammalian pluripotent stem cell-derived endodermal cells |
| WO2016122014A1 (ko) * | 2015-01-27 | 2016-08-04 | 한국생명공학연구원 | 자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도 |
| MY201637A (en) * | 2015-10-15 | 2024-03-06 | Celularity Inc | Natural killer cells and ilc3 cells and uses thereof |
| WO2018017843A1 (en) * | 2016-07-22 | 2018-01-25 | Tissue Testing Technologies Llc | Enhancement of cell cryopreservation with glycolipids |
| AU2018262788B2 (en) * | 2017-05-04 | 2024-08-15 | Mesoblast International Sàrl | Mesenchymal lineage precursor or stem cells with enhanced immunosuppression |
| JP6647240B2 (ja) | 2017-05-12 | 2020-02-14 | 米満 吉和 | 高活性ｎｋ細胞、およびその利用 |
| JP2019024418A (ja) * | 2017-07-31 | 2019-02-21 | 公立大学法人大阪府立大学 | 選択分離用培地 |
| JP6543375B1 (ja) | 2018-03-27 | 2019-07-10 | 株式会社ガイアバイオメディシン | ケモカインレセプターと細胞接着分子を発現するｃｄ３陰性細胞の集団、およびその利用 |
| WO2021041399A1 (en) * | 2019-08-29 | 2021-03-04 | Board Of Regents, The University Of Texas System | Cell cryopreservation medium |
-
2020
- 2020-03-02 JP JP2020035297A patent/JP2021136883A/ja active Pending
-
2021
- 2021-03-02 US US17/908,472 patent/US20230109717A1/en active Pending
- 2021-03-02 AU AU2021230860A patent/AU2021230860A1/en active Pending
- 2021-03-02 CN CN202180018428.7A patent/CN115279887A/zh active Pending
- 2021-03-02 WO PCT/JP2021/007863 patent/WO2021177279A1/ja not_active Ceased
- 2021-03-02 KR KR1020227033295A patent/KR20220148233A/ko active Pending
- 2021-03-02 EP EP21765044.9A patent/EP4151717A4/en active Pending
- 2021-03-02 TW TW110107331A patent/TW202140770A/zh unknown
-
2023
- 2023-07-24 JP JP2023120214A patent/JP2023126695A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021136883A5 (cg-RX-API-DMAC7.html) | ||
| CN104663649B (zh) | 人类卵母细胞冷冻保护剂 | |
| JP2019520301A5 (cg-RX-API-DMAC7.html) | ||
| JP2020103281A5 (cg-RX-API-DMAC7.html) | ||
| JP2002536078A5 (cg-RX-API-DMAC7.html) | ||
| JP2000511531A (ja) | 虚血性障害を受けた組織を蘇生し、補償するための溶液及び方法 | |
| Chambers et al. | The effect of parathyroid hormone, 1, 25‐dihydroxycholecalciferol and prostaglandins on the cytoplasmic activity of isolated osteoclastsxs | |
| CN117378598B (zh) | 一种卵母细胞冻存液及其制备方法 | |
| CN112167243B (zh) | 红细胞冻存液及快速冻存方法 | |
| CN109997844A (zh) | 灵芝多糖在家畜精液冷冻长期保存中的应用 | |
| Rubinsky et al. | Effect of ice crystal habit on the viability of glycerol-protected red blood cells | |
| CN102985532B (zh) | 胰岛的分离方法及用于保护胰岛组织的保护液 | |
| JP2004506414A5 (cg-RX-API-DMAC7.html) | ||
| JP2022528754A (ja) | 臓器を再調整するための方法および装置 | |
| CN115349514B (zh) | 一种新鲜组织冻存液及其制备方法和应用 | |
| Fuller | Organ preservation: The profit and loss account of using hypothermia to maintain viability | |
| US10894084B2 (en) | Metal-assisted and microwave-accelerated decrystallization | |
| JPH11225725A5 (cg-RX-API-DMAC7.html) | ||
| SU526331A1 (ru) | Раствор дл консервации органов | |
| JP2007501255A (ja) | 血液細胞の保存 | |
| JPH058675B2 (cg-RX-API-DMAC7.html) | ||
| CN113826614B (zh) | 一种器官保存液 | |
| CN100560049C (zh) | 一种去除口臭的凝胶型组合物 | |
| CN117356559A (zh) | 一种配套使用的大鼠胚胎冻存-复苏体系及其应用 | |
| RU2023130938A (ru) | Композиция для криоконсервации nk-клеток и состав для криоконсервации, её содержащий |